Cardiac Safety Services Market

Bioclinica (US), Laboratory Corporation of America Holdings (US) and BioTelemetry, Inc. (US) are leading players in Cardiac Safety Services Market

The cardiac safety services market is projected to reach USD 752 million by 2024 from USD 442 million in 2019, at a CAGR of 11.2%. Market growth is largely driven by factors such as the growing R&D expenditure in the pharmaceutical & biopharmaceutical industry, increased outsourcing of R&D activities, and the increasing number of clinical trials.

The prominent players operating in this market include Biotrial (France), Banook Group (France & Canada), Bioclinica (US), Certara L.P. (US), Celerion, Inc. (US), ERT, Inc. (US), Laboratory Corporation of America Holdings (US), Medpace Holdings, Inc. (US), Ncardia AG (Belgium), Richmond Pharmacology (UK), PhysioStim (France), Shanghai Medicilon Inc. (China), SGS S.A. (Switzerland), BioTelemetry, Inc. (US), IQVIA (US), and Pharmaceutical Product Development LLC (US). Players in this market focused on service launches & upgrades, expansions, mergers & acquisitions, and partnerships & agreements to develop and expand their market presence between 2016 and 2019.

To know about the assumptions considered for the study download the pdf brochure

Laboratory Corporation of America Holdings (US) is the leading player in the cardiac safety services market. LabCorp has built its expertise in entering new markets and successfully impacting them. The company has pursued competitive strategies such as acquisitions and expansions in order to solidify its presence in the market. In 2015, LabCorp acquired Covance, a prominent player in the cardiac safety services market, thus helping the firm enter this market and expand its presence. This development has significantly helped LabCorp in tapping into new revenue streams and diversifying its economic cycle. This free cash flow helps LabCorp expand into new projects; this edge over other companies is expected to strengthen its leadership position in the market.

BioTelemetry (US) is the second-largest player in the cardiac safety services market. The company holds this position owing to its strong and comprehensive global service portfolio, which includes a wide array of services such as ECG, event, blood pressure, and Holter monitoring, as well as ECHO and MUGA studies for clinical trials. BioTelemetry is a part of one of the biggest global cardiac data networks. This significantly helps the firm in enhancing its reach and revenue since it caters to a wider range of pharma & biopharma companies, thus making it a prominent player in the cardiac safety services market.

Bioclinica (US) is the third-leading player in the cardiac safety services market. It is a subsidiary of Cinven (UK). Bioclinica maintains its position in this market owing to its high brand value and strong brand recognition amongst its clientele, which further establishes the firm as a key player in the niche market for cardiac safety services. Bioclinica’s synergy with Cinven and the strength of its operational network is expected to provide the firm with financial benefits and additional support, thus expanding its business into new markets and witnessing sustainable growth during the forecast period.

Related Reports:

Cardiac Safety Services Market by Type (Standalone, Integrated), Services (ECG/Holter measurement, Blood Pressure, Cardiac Imaging, Thorough QT Study, Other Services), End User (Pharmaceutical & Biopharmaceutical Companies, CRO) - Global Forecast to 2024

Contact:
Mr. Shelly Singh
MarketsandMarkets™ INC.
630 Dundee Road
Suite 430
Northbrook, IL 60062
USA : 1-888-600-6441
[email protected]

Report Code
PH 7455
RI Published ON
11/27/2019
Choose License Type
BUY NOW
  • SHARE
X
Request Customization
Speak to Analyst
Speak to Analyst
OR FACE-TO-FACE MEETING
PERSONALIZE THIS RESEARCH
  • Triangulate with your Own Data
  • Get Data as per your Format and Definition
  • Gain a Deeper Dive on a Specific Application, Geography, Customer or Competitor
  • Any level of Personalization
REQUEST A FREE CUSTOMIZATION
LET US HELP YOU!
  • What are the Known and Unknown Adjacencies Impacting the Cardiac Safety Services Market
  • What will your New Revenue Sources be?
  • Who will be your Top Customer; what will make them switch?
  • Defend your Market Share or Win Competitors
  • Get a Scorecard for Target Partners
REQUEST A FREE WORKSHOP
ADJACENT MARKETS
REQUEST BUNDLE REPORTS
ONLINE CHAT
+1-888-600-6441
  • Call Us
  • +1-888-600-6441 (Corporate office hours)
  • +1-888-600-6441 (US/Can toll free)
  • +44-800-368-9399 (UK office hours)
CONNECT WITH US
ABOUT TRUST ONLINE
© MarketsandMarkets Research Private Ltd. All rights reserved